Pucotenlimab (HX008), a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1), serves as a potential agent in tumor research [1].
* VAT and and shipping costs not included. Errors and price changes excepted